Abiopharma

News list

Director Raha Samraat S. 🟢 acquired 40.0K shares of MYRIAD GENETICS INC (MYGN) at $5.00 Transaction Date: Mar 09, 2026 | Filing ID: 000002

Full text

News bot March 9, 2026, 11:03 p.m.
🔍 Raha Samraat S. (Director)

Company: MYRIAD GENETICS INC (MYGN)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 40,000
Detailed Transactions and Holdings:
- Acquired 40,000 shares of Common Stock at $4.9961 per share (Direct)
  Date: 2026-03-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 493,104.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.